| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 12/17/2008 | CN101322848A Composition for gastroscopy and preparation thereof |
| 12/17/2008 | CN100443476C Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 12/16/2008 | US7465848 for cardiac response; cardiotoxic, effect of an agent, e.g., a drug, e.g., a small molecule drug, on the developing zebrafish cardiovascular (CV) system can predict the effects of the agent on the CV system in humans |
| 12/16/2008 | US7465548 associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, urological diseases, respiratory diseases and gastroenterological diseases |
| 12/16/2008 | US7465434 Expressing a fibrin-binding protein using a nucleic acid sequence modified to delete a sequence coding for the serine protease domain to remove fibrinolytic activating properties; injecting compound of the protein and a contrast agent; and radiographically detecting the compound bound to a blood clot |
| 12/16/2008 | CA2336191C Hyperpolarized gas transport devices and associated transport method |
| 12/16/2008 | CA2249173C Diagnostic agent for liver function |
| 12/11/2008 | WO2008151112A1 Use of 3-alkanoyloxymethoxycarbonyl nitroxide esters as oximetry probes for measurement of oxygen status in tissues |
| 12/11/2008 | WO2008150516A1 A method for testing and screening p38 map kinase modifiers |
| 12/11/2008 | WO2008150467A1 Screening assays for inhibitors of beta amyloid peptide ion channel formation |
| 12/11/2008 | WO2008148877A2 Paramagnetic biomolecule complexes and uses thereof in the assessment of organ function |
| 12/11/2008 | WO2008148546A2 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label |
| 12/11/2008 | WO2008100596A3 Biomarkers of neurodegenerative disease |
| 12/11/2008 | WO2008093005A3 Preparation for detection of a salivary malfunction |
| 12/11/2008 | WO2008091617A3 Method for detecting age related macular degeneration in a subject |
| 12/11/2008 | WO2008066626A3 METHODS FOR THE TREATMENT OF Aβ RELATED DISORDERS AND COMPOSITIONS THEREFOR |
| 12/11/2008 | WO2008008819A3 Diagnosis and treatment of neurological inflammation |
| 12/11/2008 | WO2008002620A3 Cell model for alzheimer's disease pathology |
| 12/11/2008 | WO2007146359A3 Sea lice antigen vaccines |
| 12/11/2008 | WO2006076519A3 Mycobacterial mutants affecting host apoptosis |
| 12/11/2008 | US20080306152 Compositions containing prodrugs of florfenicol and methods of use |
| 12/11/2008 | US20080305106 Novel Gene Disruptions, Composition and Methods Relating Thereto |
| 12/11/2008 | US20080305049 Mri Contrast Agents for Diagnosis and Prognosis of Tumors |
| 12/11/2008 | US20080305048 Self-Assembling Nanoparticle Conjugates |
| 12/11/2008 | US20080305047 Chemosensors Based on Quantum Dots and Oxazine Compounds |
| 12/11/2008 | US20080305046 Molecular imaging methods for diagnosis and evaluation of ocular and systemic diseases |
| 12/11/2008 | US20080305045 Methods of synthesis of non-toxic multifunctional nanoparticles and applications |
| 12/11/2008 | US20080305044 Engineered Antibodies and Immunoconjugates |
| 12/11/2008 | US20080305043 Assay Method |
| 12/11/2008 | US20080305041 Pf4 Pharmacophores and Their Uses |
| 12/11/2008 | US20080305040 In Vivo or in Vitro Method For Detecting Amyloid Deposits Having at Least One Amyloidogenic Protein |
| 12/11/2008 | US20080305039 Facilitated Transport of Bisphosphonates by Vitamin C |
| 12/11/2008 | US20080305037 Linkers for anchoring targeting ligands |
| 12/11/2008 | CA2724432A1 Compositions and methods for binding lysophosphatidic acid |
| 12/11/2008 | CA2721401A1 Paramagnetic biomolecule complexes and uses thereof in the assessment of organ function |
| 12/11/2008 | CA2688544A1 Use of 3-alkanoyloxymethoxycarbonyl nitroxide esters as oximetry probes for measurement of oxygen status in tissues |
| 12/11/2008 | CA2687819A1 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label |
| 12/10/2008 | EP2000536A2 Tat-derived transport polypeptides |
| 12/10/2008 | EP1998813A2 Method to produce hyperpolarised carboxylates and sulphonates in the presence of inorganic cations |
| 12/10/2008 | EP1998812A2 Method to assess surfactant adsorption on skin |
| 12/10/2008 | EP1429733B1 Preparation of microparticles |
| 12/10/2008 | EP1021464B1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 12/10/2008 | CN101321750A Multimeric magnetic resonance contrast agents |
| 12/10/2008 | CN101321541A Novel imaging agents for fibrosis |
| 12/10/2008 | CN101320607A Preparation method of ferroferric oxide/multi-wall carbon nano-tube magnetic nanometer composite material |
| 12/10/2008 | CN101319101A Method of preparing water-soluble nanocrystalline |
| 12/10/2008 | CN101318023A Magnetic resonance contrast agent comprising iron-binding protein |
| 12/09/2008 | US7462459 Bioassays for L-type amino acid transporter 1 (LAT1); screening for therapeutic, cytotoxic or imaging compounds used in the treatment or diagnosis of neurological diseases |
| 12/09/2008 | US7462366 Drug delivery particle |
| 12/09/2008 | US7462352 Methods of treatng B-cell diseases using humanized anti-CD19 antibodies |
| 12/09/2008 | US7462347 cyanine dyes and/or with lipophilic side chains; to detect stained cells both in vivo and in vitro; increased signal to noise ratio for rapidly labeling; improved solubility |
| 12/09/2008 | US7462346 Photochemical demethylation reactions in solutions of thiazine dyes (dye molecules act as both sensitizer and substrate) are reduced by quenching triple-state dye molecules (incorporating zinc or sodium ions or both), returning them to the unreactive around state |
| 12/09/2008 | US7462345 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 12/09/2008 | CA2417724C Method of magnetic resonance investigation of a sample using a nuclear spin polarised mr imaging agent |
| 12/09/2008 | CA2214737C Microparticles, media containing the latter for ultrasonic diagnosis as well as process for the production of the particles and media |
| 12/04/2008 | WO2008147365A1 Composition for increasing intracellular nitric oxide and method for the same |
| 12/04/2008 | WO2008145609A1 Method of making covalent conjugates with his-tagged proteins |
| 12/04/2008 | WO2008144931A1 Compositions and methods for modulating gated ion channels |
| 12/04/2008 | WO2008144925A1 Iap bir domain binding compounds |
| 12/04/2008 | WO2008036675A3 Compositions and methods of enhancing immune responses |
| 12/04/2008 | WO2007136781A3 Rapid detection of mycobacterium tuberculosis and antimicrobial drug resistance |
| 12/04/2008 | WO2007127231A3 Magnetic resonance-detectable, ultrasound-detectable and/or radiopaque microcapsules and uses thereof |
| 12/04/2008 | WO2007100628A3 Destruction of spores through glycoconjugate enhanced phagocytosis |
| 12/04/2008 | US20080300220 Linkable Lewis X Analogs |
| 12/04/2008 | US20080299047 Method for preparation of water-soluble and dispersed iron oxide nanoparticles and application thereof |
| 12/04/2008 | US20080299046 Methods for controlling surface functionality of metal oxide nanoparticles, metal oxide nanoparticles having controlled functionality, and uses thereof |
| 12/04/2008 | US20080299045 Composition for Prevention, Treatment, and Diagnosis of Chronic Obstructive Pulmonary Disease (Copd) |
| 12/04/2008 | US20080299044 Saccharide Fluorescent Substrates, Preparation Method and Uses Thereof |
| 12/04/2008 | US20080299043 having superior solubility anf miscibility with membrane components of liposomes; suitable for a liposome contrast medium selective for a lesion such as vascular diseases; chelate compound |
| 12/04/2008 | US20080299042 Membrane Associated Molecules |
| 12/04/2008 | US20080299039 Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier |
| 12/04/2008 | CA2687574A1 Compositions useful for reducing nephrotoxicity and methods of use thereof |
| 12/03/2008 | EP1997894A2 Biosynthetic binding protein for cancer marker |
| 12/03/2008 | EP1997801A1 Higher fatty acid triester compound having diethylenetriamine-type metal chelate structure |
| 12/03/2008 | EP1997076A2 Cascade analysis for intestinal contraction detection |
| 12/03/2008 | EP1996239A2 Compositions for visualization of vitreous body and methods of using same |
| 12/03/2008 | EP1651189B1 Novel metaxalone compositions |
| 12/03/2008 | CN101316812A Precursor compound of radioactive halogen labeled organic compound |
| 12/03/2008 | CN101316616A Method of dynamic nuclear polarisation (DNP) using a trityl radical and a paramagnetic metal ion |
| 12/03/2008 | CN101314049A Novel targeted microbubble contrast medium |
| 12/03/2008 | CN101314048A Body mould for mri and MRI system |
| 12/03/2008 | CN101313869A Testing instrument for cold-hot drink of large mouse |
| 12/02/2008 | USRE40594 Inhibitors of the bitter taste response |
| 12/02/2008 | US7459283 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 12/02/2008 | US7459144 Process for preparation of MR contrast agents |
| 12/02/2008 | US7459143 Monoclonal antibodies; determination blood coagulation; dissolving clots; administering deimmunized immunointeractive molecules; using planar or computer assisted tomographic nuclear medicine scan to visualize a clot |
| 12/02/2008 | US7459142 High viscosity embolizing compositions comprising prepolymers |
| 12/02/2008 | CA2372572C A process for the preparation of an mr contrast agent |
| 12/02/2008 | CA2341624C Stable spray-dried protein formulations |
| 12/02/2008 | CA2263568C Methods for diagnostic imaging using a contrast agent and a renal vasodilator |
| 12/02/2008 | CA2182062C Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments comprising them |
| 11/27/2008 | WO2008144753A2 Antibodies to tnf alpha and use thereof |
| 11/27/2008 | WO2008144065A1 Ophthalmic formulations of amyloid- contrast agents and methods of use thereof |
| 11/27/2008 | WO2008144052A2 Bioluminescent imaging of stem cells |
| 11/27/2008 | WO2008143958A1 Use of somatostatin analogs in myocardial perfusion imaging |
| 11/27/2008 | WO2008143916A2 Prokinetic agent for bowel preparation |
| 11/27/2008 | WO2008108944A3 Integrated photoactive small molecules and uses thereof |
| 11/27/2008 | WO2008064043A3 Methods for determining therapeutic efficacy of quinolone analogs |
| 11/27/2008 | WO2008030988A3 Selectively targeted antimicrobial peptides and the use thereof |
| 11/27/2008 | WO2007123723A3 Diagnosis and treatment of alzheimer's disease |